Abhinav Jain - 03 Oct 2025 Form 4 Insider Report for AYTU BIOPHARMA, INC (AYTU)

Reporting relationship: Director
Issuer ticker: AYTU
Reported as of: 03 Oct 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Oct 2025, 16:09:15 UTC
Prior SEC filing: 08 Aug 2025
Next SEC filing: 24 Oct 2025
Source filing: View source filing
Reporting owner signature: /s/ Ryan J. Selhorn as attorney-in-fact for Abhinav Jain

Key filing fact

Abhinav Jain filed Form 4 for AYTU BIOPHARMA, INC (AYTU) on 07 Oct 2025.

Key facts

This page summarizes Abhinav Jain's Form 4 filing for AYTU BIOPHARMA, INC (AYTU).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 07 Oct 2025, 16:09.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

CIK 0001981291 Primary reporting owner

Relationship: Director
Address: C/O AYTU BIOPHARMA, INC., 7900 EAST UNION AVENUE, SUITE 920, DENVER
Signature: /s/ Ryan J. Selhorn as attorney-in-fact for Abhinav Jain
Signature date: 07 Oct 2025

Shares, units, or other non-derivative securities reported in this filing.

AYTU transaction

Award

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Explanation of responses 1 footnote

Footnote F1

Grant of restricted stock, which vest on October 3, 2026.

SEC remarks

Exhibit 24: Power of Attorney